Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NWLI
2501
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $9.39M | ﹤0.01% |
41,829
+1,625
| +4% | +$387K |
|
2502
Alaunos Therapeutics
TCRT
$4.52M
| $9.38M | ﹤0.01% |
23,678
+111
| +0.5% | +$51.8K |
|
2503
Keros Therapeutics
KROS
$199M
| $9.37M | ﹤0.01% |
220,527
+46,506
| +27% | +$2.52M |
|
|
DFTX
2504
Definium Therapeutics
DFTX
$5.61B
| $9.36M | ﹤0.01% |
+180,806
| New | +$9.49M |
|
|
DX
2505
Dynex Capital
DX
$3.13B
| $9.35M | ﹤0.01% |
501,283
+92,594
| +23% | +$1.82M |
|
|
MILE
2506
DELISTED
Metromile, Inc. Common Stock
MILE
| $9.33M | ﹤0.01% |
1,019,868
+340,547
| +50% | +$3.05M |
|
2507
Ennis
EBF
$553M
| $9.33M | ﹤0.01% |
433,448
+6,277
| +1% | +$133K |
|
|
CATC
2508
DELISTED
CAMBRIDGE BANCORP
CATC
| $9.33M | ﹤0.01% |
112,397
+10,151
| +10% | +$866K |
|
|
SFT
2509
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $9.32M | ﹤0.01% |
108,601
+51,990
| +92% | +$4.16M |
|
2510
Coursera
COUR
$1.74B
| $9.29M | ﹤0.01% |
+234,963
| New | +$10.1M |
|
|
API
2511
Agora
API
$348M
| $9.27M | ﹤0.01% |
222,380
+192,443
| +643% | +$8.9M |
|
|
THR
2512
DELISTED
Thermon Group Holdings
THR
| $9.26M | ﹤0.01% |
543,456
+8,851
| +2% | +$165K |
|
2513
Nkarta
NKTX
$155M
| $9.22M | ﹤0.01% |
291,075
-35,006
| -11% | -$1.01M |
|
2514
PDF Solutions
PDFS
$2.12B
| $9.22M | ﹤0.01% |
507,242
+21,057
| +4% | +$377K |
|
2515
V2X
VVX
$2.5B
| $9.18M | ﹤0.01% |
192,905
+2,304
| +1% | +$119K |
|
|
BGFV
2516
DELISTED
Big 5 Sporting Goods
BGFV
| $9.18M | ﹤0.01% |
357,287
+175,463
| +97% | +$4.31M |
|
2517
IMAX
IMAX
$2.77B
| $9.17M | ﹤0.01% |
426,516
+4,357
| +1% | +$93.9K |
|
2518
Annexon
ANNX
$885M
| $9.13M | ﹤0.01% |
405,732
+43,598
| +12% | +$966K |
|
|
ISEE
2519
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.13M | ﹤0.01% |
1,447,066
+112,086
| +8% | +$723K |
|
2520
Peabody Energy
BTU
$2.69B
| $9.13M | ﹤0.01% |
1,150,948
+89,765
| +8% | +$532K |
|
|
MSGN
2521
DELISTED
MSG Networks Inc.
MSGN
| $9.12M | ﹤0.01% |
625,673
+2,236
| +0.4% | +$34.8K |
|
2522
Peoples Bancorp
PEBO
$1.49B
| $9.11M | ﹤0.01% |
307,700
+4,702
| +2% | +$153K |
|
|
AFMD
2523
DELISTED
Affimed
AFMD
| $9.1M | ﹤0.01% |
107,066
+2,564
| +2% | +$234K |
|
2524
Veritone
VERI
$109M
| $9.1M | ﹤0.01% |
461,520
+33,777
| +8% | +$733K |
|
2525
Arlo Technologies
ARLO
$1.67B
| $9.09M | ﹤0.01% |
1,342,267
+44,602
| +3% | +$291K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.